Header Logo

Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum ?-lactamase producing gram-negative bacteria.

Fong JJ, Ros? L, Radigan EA. Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum ?-lactamase producing gram-negative bacteria. Ann Pharmacother. 2012 Mar; 46(3):347-52.

View in: PubMed